Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis

European Journal of Neurology

Volumn 16, Issue 6, 2009, Pages 713-720

  Putzki, N ^a,b   Fischer, J ^c   Gottwald, K ^c   Reifschneider, G ^c   Ries, S ^c   Siever, A ^c   Hoffmann, F ^c   Kafferlein W ^c   Kausch, U ^c   Liedtke, M ^c   Kirchmeier, J ^c   Gmund S ^c   Richter, A ^c   Schicklmaier, P ^c   Niemczyk, G ^c   Wernsdorfer C ^c   Hartung, H P ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c Cantonal Hospital ^*

Author keywords

Clinical trial; Efficacy; Interferon beta 1a; Multiple sclerosis; Quality of life

Indexed keywords

BETA1A INTERFERON;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OCCUPATIONAL HEALTH; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SCORING SYSTEM;

ADAPTATION, PSYCHOLOGICAL; ADJUVANTS, IMMUNOLOGIC; ADULT; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; GERMANY; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; SEVERITY OF ILLNESS INDEX; SICK LEAVE; TIME FACTORS;

EID: 65449167186     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02572.x     Document Type: Article

References (35)

1. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnestic process. Brain 2003 126 : 770 782. (Pubitemid 36372978)
2. Galetta SL, Markowitz C, Lee AG. Immunomodulatory agents for the treatment of relapsing multiple sclerosis. A systematic review. Arch Intern Med 2002 162 : 2161 2169. (Pubitemid 35231583)
3. Goodin DS. Treatment of multiple sclerosis with human beta interferon. Int MS J 2005 12 : 96 108. (Pubitemid 41712027)
4. Roessler RT, Rumrill PD. Multiple sclerosis and employment barriers: A systemic perspective on diagnosis and intervention. Work 2003 21 : 17 23. (Pubitemid 37038328)
5. Rich SJ, Coleman JC, Cook R, et al. Stepped-care approach to treating MS: a managed care treatment algorithm. J Manag Care Pharm 2004 10 (2 Suppl S-b S26 S32.
6. Rieckmann P, Toyka KV, Bassetti C, et al., Multiple Sclerosis Therapy Consensus Group. Escalating immunotherapy of multiple sclerosis - new aspects and practical application. J Neurol 2004 25 : 1329 1339.
7. Filippini G, Munari L, Incorvaia B, et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003 15 : 545 552. (Pubitemid 36207471)
8. Forbes RB, Lees A, Waugh N, Swingler RJ. Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis. Br Med J 1999 319 : 1529 1533.
9. Arnoldus JH, Killestein J, Pfennings LE, Jelles B, Uitdehaag BM, Polman CH. Quality of life during the first 6 months of interferon-beta treatment in patients with MS. Mult Scler 2000 6 : 338 342.
10. Cox D, Stone J. Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis. J Neurosci Nurs 2006 38 : 167 171.
11. Lily O, McFadden E, Hensor E, Johnson M, Ford H. Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment. Mult Scler 2006 12 : 808 813. (Pubitemid 46111775)
12. Miltenburger C, Kobelt G. Quality of life and cost of multiple sclerosis. Clin Neurol Neurosurg 2002 104 : 272 275.
13. Janardhan V, Bakshi R. Quality of life and it's relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Intern Med 2000 57 : 1485 1491.
14. Miller A, Dishon S. Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual Life Res 2006 15 : 259 271. (Pubitemid 43230116)
15. Montel SR, Bungener C. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis. Mult Scler 2007 13 : 393 401. (Pubitemid 46706001)
16. Kobelt G, Berg J, Lindgren P, et al. Costs and quality of life of multiple sclerosis in Germany. Eur J Health Econ 2006 7 : 34 44. (Pubitemid 46318953)
17. Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 2006 77 : 918 926. (Pubitemid 44174075)
18. Patti F, Russo P, Pappalardo A, Macchia F, Civalleri L, Paolillo A. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study. J Neurol Sci 2007 252 : 121 129. (Pubitemid 46055242)
19. Chang CH, Cella D, Fernandez O, et al. Quality of life in multiple sclerosis patients in Spain. Mult Scler 2002 8 : 527 531. (Pubitemid 35396405)
20. Miller DM, Rudick RA, Baier M, et al. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 2003 9 : 1 5. (Pubitemid 36253688)
21. Morales-Gonzáles JM, Benito-León J, Rivera-Navarro J, Mitchell AJ, GEDMA Study Group. A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study. Mult Scler 2004 10 : 47 54. (Pubitemid 38100526)
22. Zivadinov R, Zorzon M, Tommasi MA, et al. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. J Neurol Sci 2003 216 : 113 118. (Pubitemid 37371875)
23. Patti F, Pozzilli C, Montanari E, et al. Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler 2007 6 : 783 791. (Pubitemid 47074103)
24. Forbes A, While A, Mathes L, Griffiths P. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil 2006 20 : 67 78. (Pubitemid 43246334)
25. Hopman WM, Coo H, Edgar CM, McBride EV, Day AG, Brunet DG. Factors associated with health-related quality of life in multiple sclerosis. Can J Neurol Sci 2007 34 : 160 166. (Pubitemid 47000117)
26. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13 : 227 231. (Pubitemid 13158528)
27. EuroQoL & Group. EuroQoL - a new facility for the measurement of health-related quality of life. Health Policy 1990 6 : 199 208.
28. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 1998 316 : 736 741. (Pubitemid 28121072)
29. König HH, Bernert S, Angermeyer MC. Gesundheitszustand der deutschen Bevölkerung: Ergebnisse einer repräsentativen Befragung mit dem EuroQoL-Instrument [Health status of the German population: results of a representative survey using the EuroQoL questionnaire]. Gesundheitswesen 2005 67 : 173 182.
30. Busche KD, Fisk JD, Murray TJ, Metz LM. Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci 2003 30 : 137 142. (Pubitemid 36717996)
31. Barton GR, Sach TH, Avery AJ, et al. A comparison of the performance of the EQ-5D and SF-6D for individuals aged >/= 45 years. Health Econ 2008 17 : 815 832.
32. Longworth L, Bryan S. An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 2003 12 : 1061 1067. (Pubitemid 38035310)
33. Parkin D, Jacoby A, McNamee P, Miller P, Thomas S, Bates D. Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosurg Psychiatry 2000 68 : 144 149. (Pubitemid 30245835)
34. Haupts M, Elias G, Hardt C, et al. Quality of life in patients with remitting-relapsing multiple sclerosis in Germany. Nervenarzt 2003 74 : 144 150. (Pubitemid 36606011)
35. Vermersch P, de Seze J, Delisse B, Lemaire S, Stojkovic T. Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment. Mult Scler 2002 8 : 377 381.